Abstract
Non-small cell lung cancer today has several reported testimonies of aberrant promoter hypermethylation of tumor suppressing genes. In this study, a group of five genes (CDKN2A, APC, MGMT, DAPK and RASSF1) have been evaluated, using epigenetic tools and techniques to investigate their frequency of hypermethylation, prediction of CpG islands and expected primers along with their phylogenetic relationships (to analyze these prospective biomarkers) and their possible substitutes to enhance their clinical potential as drug treatment targets. During the course of research, Adenomatosis Polyposis Coli Tumor Suppressor gene, an antagonist of the Wnt signaling pathway, was seen to show maximum methylation frequency of 48 % at 223, 243, 250, 255 and 262 bp and be closely related to DAPK2 gene using phylogenetic analysis, suggesting that both of these genes can act as possible novel targets for designing drugs for non-small cell lung cancer.
Similar content being viewed by others
References
Alberg AJ, Ford JG, Samet JM (2007) Epidemiology of lung cancer: ACCP evidence based clinical practice guidelines (2nd edition). Chest 132:29S–55S
Brabender J, Henning U, Kathleen DD, Ralf M, Paul MS, Reginald VL, Kumari W, Christopher EL, JiMin P, Stephen JM, Peter VD (2001) Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene 20:3528–3532
Brambilla E, Travis WD, Colby TV (2001) The new World Health Organization classification of lung tumours. Eur Respir J 18:1059–1068
Greenman C, Stephens P, Smith R (2007) Patterns of somatic mutation in human cancer genomes. Nature 446:153–158
Grunau C, Eric R, Rosenthal E, Roizes G (2001) MethDB- a public database for DNA methylation data. Nucleic Acids Res 29(1):270–274
Hakem R (2008) DNA-damage repair; the good, the bad, and the ugly. J Embryol 27:589–605
He XM, Chang SH, Zhang JJ, Zhao Q, Xiang HZ, Wang J (2008) MethyCancer: the database of human DNA methylation and cancer. Nucleic Acids Res 36:D836–D841
Jemal A, Bray F, Center MM (2011) Global cancer statistics. Cancer J Clin 61:69–90
Kanehisa M, Goto S (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27–30
Kim DH, Nelson HH, Wiencke JK, Christiani DC, Wain JC, Mark EJ, Kelsey KT (2001) Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Oncogene 20(14):1765–1770
Langer CJ, Besse B, Gualberto A (2010) The evolving role of histology in the management of advanced non-small-cell lung cancer. J Clin Oncol 28:5311–5320
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23(21):2947–2948
Ongenaert M, Leander VN, Tim DM, Gerben M, Bekaert S, Wim VC (2008) PubMeth: a cancer methylation database combining text-mining and expert annotation. Nucleic Acids Res 36(1):836–841
Osada H, Takahashi T (2002) Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 21:7421–7434
Peto R, Darby S, Deo H (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. Br Med J 321:323–329
Phillips T (2008) The role of methylation in gene expression. Nat Educ 1(1):116
Purohit R, Kumar A (2013) Cancer associated E17K mutation causes rapid conformational drift in AKT1 pleckstrin homology (PH) domain. PLoS One 8(5):e64364
Purohit R, Sethumadhavan R (2009) Structural basis for the resilience of Darunavir (TMC114) resistance major flap mutations of HIV-1 protease. Interdiscip Sci 1(4):320–328
Purohit R, Rajendran V, Sethumadhavan R (2001) Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and Isoniazid susceptibility: an in silico analysis. J Mol Model 17(4):869–877
Purohit R, Rajendran V, Sethumadhavan R (2011) Studies on adaptability of binding residues and flap region of TMC-114 resistance HIV-1 protease mutants. J Biomol Struct Dyn 29(1):137–152
Rajendran V, Purohit R, Sethumadhavan R (2012) In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein. Amino Acids 43(2):603–615
Rekhtman N, Ang DC, Sima CS (2011) Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. Mod Pathol 24:1348–1359
Rosti G, Bevilacqua G, Bidoli P (2006) Small cell lung cancer. Ann Oncol 17(ii):5–10
Russo VEA (1996) Epigenetic mechanisms of gene regulation. Genes Dev 11:1357–1492
Safar AM, Horace S, Xiaobo S (2005) Methylation profiling of archived non-small cell lung cancer: a promising prognostic system. Clin Cancer Res 11:4400–4405
Shields PG (2002) Molecular epidemiology of smoking and lung cancer. Oncogene 21:6870–6876
Toyooka S, Tokumo M, Shigematsu H, Matsuo K, Asano H, Tomii K, Ichihara S, Suzuki M, Aoe M, Date H, Gazdar AF, Shimizu N (2006) Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Cancer Res 66(3):1371–1375
Travis WD, Brambilla E, Muller-Hermelink HK (2004) Pathology and genetics: tumors of the lung, pleura, thymus and heart. Int Agency Res Cancer 1:12–124
Tsou JA, Shen LY, Siegmund KD, Long TI, Laird PW, Seneviratne CK, Koss MN, Pass HI, Hagen JA, Laird-Offringa IA (2005) Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. Lung Cancer 47(2):193–204
Vallböhmer D, Brabender J, Yang D, Schneider PM, Metzger R, Danenberg KD, Hölscher AH, Danenberg PV (2006) DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value. Clin Lung Cancer 8(1):39–44
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10:789–799
Wang J, Lee JJ, Wang L, Liu DD, Lu C, Fan YH, Hong WK, Mao L (2004) Value of p16INK4A and RASSF1 promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer. Clin Cancer Res 10:6119–6125
Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden T (2012) Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13:134
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singh, A.N., Singh, S., Ramteke, P.W. et al. In silico epigenetic profiling of hypermethylated genes in non-small cell lung cancer. Netw Model Anal Health Inform Bioinforma 3, 71 (2014). https://doi.org/10.1007/s13721-014-0071-0
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13721-014-0071-0